These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 4945000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Data on changes in blood and urinary uric acid induced by a urate oxidase].
    Villiaumey J, Larget-Piet B, Rotterdam M.
    Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):138-40. PubMed ID: 4563394
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R, Vindel J, Lamarche M, Kissel P.
    Presse Med (1893); 1968 Dec 14; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical experience with a new uricolytic agent].
    Alessandri C, Violi F, Bonavita MS.
    Recenti Prog Med; 1986 Mar 14; 77(3):147-8. PubMed ID: 3715181
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S, Roche B, Dorent R, Koeger AC, Borget C, Wrona N, Bourgeois P.
    Rev Rhum Engl Ed; 1995 May 14; 62(5):392-4. PubMed ID: 7655872
    [Abstract] [Full Text] [Related]

  • 9. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb 07; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia].
    Prost A, Fontenaille C, Guiheneuc P, Héron B, Lucas J.
    Rev Rhum Mal Osteoartic; 1974 Jan 07; 41(1):33-9. PubMed ID: 4820524
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)].
    Vigo P, Ortolani S, Soldati L, Girardello R, Fleischmann L, Polli EE.
    Haematologica; 1981 Oct 07; 66(5):656-66. PubMed ID: 6796473
    [No Abstract] [Full Text] [Related]

  • 18. Pegloticase and lowering blood pressure in refractory gout; is it uric acid or hydrogen peroxide?
    Fini MA, Stenmark KR.
    Eur J Intern Med; 2019 Nov 07; 69():e11-e12. PubMed ID: 31471165
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.